Chylothorax is an uncommon form of pleural effusion characterized by the presence of chylomicrons, triglycerides and cholesterol in the physical and chemical examination of the pleural fluid. It may have poor prognosis if not properly treated. Currently, conservative measures are the first line of treatment for managing chylothorax. The aim of our study is to show and suggest the use of octreotide in association with talc poudrage as good option to manage post-operative a severe chylothorax.
Use of Octreotide in association with talc poudrage for the management of a severe chylothorax: A case report / Lovati, Eleonora; Ruggiero, Ciro; Masciale, Valentina; Stefani, Alessandro; Morandi, Uliano; Aramini, Beatrice. - In: INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS. - ISSN 2210-2612. - volume 79:(2021), pp. 156-159. [10.1016/j.ijscr.2021.01.018]
Use of Octreotide in association with talc poudrage for the management of a severe chylothorax: A case report
Eleonora Lovati;Ciro Ruggiero;Valentina Masciale;Alessandro Stefani;Uliano Morandi;Beatrice Aramini
Conceptualization
2021
Abstract
Chylothorax is an uncommon form of pleural effusion characterized by the presence of chylomicrons, triglycerides and cholesterol in the physical and chemical examination of the pleural fluid. It may have poor prognosis if not properly treated. Currently, conservative measures are the first line of treatment for managing chylothorax. The aim of our study is to show and suggest the use of octreotide in association with talc poudrage as good option to manage post-operative a severe chylothorax.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Use of Octreotide in association with talc poudrage for the management of a severe chylotorax- A case report.pdf
Open access
Descrizione: Articolo principale
Tipologia:
Versione pubblicata dall'editore
Dimensione
859.1 kB
Formato
Adobe PDF
|
859.1 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
